bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
49629-024 -
Package NDC
49629-024-99 -
SPL ID
86d1348e-afd7-4558-8d03-707b6bc3e531
What the source publishes
- Labeler
- Rottendorf Pharma GmbH
- Active ingredients
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- Form
- TABLET
- Administrative status
- present-in-source-snapshot
- Marketing status
- DRUG FOR FURTHER PROCESSING
- Product type
- DRUG FOR FURTHER PROCESSING
Names this record is found by
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- BICTEGRAVIR SODIUM
- EMTRICITABINE
- TENOFOVIR ALAFENAMIDE FUMARATE
Complete source data
{
"name": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate",
"splId": "86d1348e-afd7-4558-8d03-707b6bc3e531",
"labels": [],
"routes": [],
"labeler": "Rottendorf Pharma GmbH",
"finished": false,
"packaging": [
{
"description": "27878 TABLET in 1 DRUM (49629-024-99)",
"package_ndc": "49629-024-99",
"identifierStatus": "well-formed",
"marketing_start_date": "15-APR-26"
}
],
"productId": "49629-024_86d1348e-afd7-4558-8d03-707b6bc3e531",
"useDomain": "unknown",
"dosageForm": "TABLET",
"productNdc": "49629-024",
"deaSchedule": null,
"genericName": "bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate",
"productType": "DRUG FOR FURTHER PROCESSING",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BICTEGRAVIR SODIUM",
"strength": "50 mg/1"
},
{
"name": "EMTRICITABINE",
"strength": "200 mg/1"
},
{
"name": "TENOFOVIR ALAFENAMIDE FUMARATE",
"strength": "25 mg/1"
}
],
"applicationNumber": null,
"marketingCategory": "DRUG FOR FURTHER PROCESSING",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20180207",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:49629-024_86d1348e-afd7-4558-8d03-707b6bc3e531"